Hepatic arterial port systems for treatment of liver metastases: Factors affecting patency and adverse events

Journal of Vascular and Interventional Radiology

Volumn 15, Issue 8, 2004, Pages 825-833

  Ricke, Jens ^a   Hildebrandt, Bert ^a   Miersch, Alexandra ^a   Nicolaou, Annett ^a   Warschewske, Guesjal ^a   Teichgräber, Ulf ^a   Hänninen, Enrique Lopez ^a   Riess, Hanno ^a   Felix, Roland ^a  

^a HUMBOLDT UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; IRINOTECAN; MITOMYCIN; OXALIPLATIN; PLATINUM; POLYETHYLENE;

ADULT; AGED; ARTERY CATHETERIZATION; ARTICLE; BLOOD TOXICITY; BRACHYTHERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CELIAC ARTERY; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; DRUG TOXICITY; ENDOPROSTHESIS LOOSENING; FEMALE; HEPATIC ARTERY; HUMAN; HYPERTHERMIC THERAPY; IMPLANTABLE PORT SYSTEM; LIVER METASTASIS; MAJOR CLINICAL STUDY; MALE; MINIMALLY INVASIVE SURGERY; OUTCOMES RESEARCH; PHASE 2 CLINICAL TRIAL; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SALVAGE THERAPY; SIDE EFFECT; SPLEEN ARTERY; SURVIVAL RATE; SURVIVAL TIME;

EID: 4043159145     PISSN: 10510443     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.RVI.0000136992.96374.60     Document Type: Article

References (24)

1. Kemeny N, Daly J, Reichman B, Geller N, Botet J, Oderman P. Intrahepatic or systemic infusion of fluorodeoxyuridine in patients with liver metastases from colorectal carcinoma: a randomized trial. Ann Intern Med 1987; 107: 459-465.
2. Hohn DC, Stagg RJ, Friedman MA, et al. A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to liver: the Northern Oncology Group trial. J Clin Oncol 1989; 7:1646-1654.
3. Chang AE, Schneider PD, Sugarbaker PH, Simpson C, Culnane M, Steinberg SM. A prospective randomized trial of regional versus systematic continuous fluorodeoxyuridine chemotherapy in the treatment of colorectal liver metastases. Ann Surg 1987; 206:685-693.
4. Martin JK Jr, O'Connell MJ, Wieand HS, et al. Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. Arch Surg 1990; 125:1022-1027.
5. Kemeny MM, Goldberg D, Beatty JD, et al. Results of a prospective randomized trial of continuous regional chemotherapy and hepatic resection as treatment of hepatic metastases from colorectal cancer. Cancer 1986; 57:492-498.
6. Rougier P, Laplanche A, Huguier M, et al. Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial. J Clin Oncol 1992; 10:1112-1118.
7. Allen-Mersh TG, Earlam S, Fordy C, Agrams K, Joughton J. Quality of life and survival with continuous hepaticartery floxuridine infusion for colorectal liver metastases. Lancet 1994; 344: 1255-1260.
8. Kerr DJ, McArdle CS, Ledermann J, et al. Intrahepatic arterial versus intravenous fluorouracil and folinic acid for colorectal cancer liver metastases: a multicentre randomised trial. Lancet 2003; 361:368-373.
9. Lorenz M, Muller HH. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. J Clin Oncol 2000; 18:243-254.
10. O'Connell MJ, Nagorney DM, Bernath AM, et al. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. J Clin Oncol 1998; 16:2528-2533.
11. Kemeny N, Huang Y, Cohen AM, et al. Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer. N Engl J Med 1999; 341:2039-2048.
12. Herrmann KA, Waggershauser T, Sittek H, Reiser MF. Liver intraarterial chemotherapy: use of the femoral artery for percutaneous implantation of catheter-port systems. Radiology 2000; 215:294-299.
13. Tanaka T, Arai Y, Inaba Y, et al. Radiologic Placement of Side-hole Catheter with Tip Fixation for Hepatic Arterial Infusion Chemotherapy. J Vasc Interv Radiol 2003; 14:63-68.
14. Wickremesekera JK, Cannan RJ, Stubbs RS. Hepatic artery access ports: recognizing and avoiding the problems. Aust NZ J Surg 2000; 70:496-502.
15. Niederhuber JE, Ensminger W, Gyves JW, Liepman M, Doan K, Cozzi E. Totally implanted venous and arterial access system to replace external catheters in cancer treatment. Surgery 1982; 92:706-712.
16. Strum S, McDermed J, Korn A, Joseph C. Improved methods for venous access: the Port-A-Cath, a totally implanted catheter system. J Clin Oncol 1986; 4:596-603.
17. Shindoh N, Ozaki Y, Kyogoku S, Yamana D, Sumi Y, Katayama H. Stabilization of a percutaneously implanted port catheter system for hepatic artery chemotherapybinfusion. Cardiovasc Intervent Radiol 1999; 22:344-347.
18. Grosso M, Zanon C, Mancini A, et al. Percutaneous implantation of a catheter with subcutaneous reservoir for intraarterial regional chemotherapy: technique and preliminary results. Cardiovasc Intervent Radiol 2000; 23:202-210.
19. Hildebrandt B, Meyer L, Bechstein WO, et al. Continuation of regional chemotherapy of hepatic neoplasms despite occlusion of the hepatic artery-report of four cases. Anticancer Drugs 2002; 13:663-669.
20. Gonda T, Ishida H, Yoshinaga K, Sugihara K. Microvasculature of small liver metastases in rats. J Surg Res 2000; 94:43-48.
21. Tsalic M, Bar-Sela G, Beny A, Visel B, Haim N. Severe toxicity related to the 5-fluorouracil/leucovorin combination (the Mayo Clinic regimen): a prospective study in colorectal cancer patients. Am J Clin Oncol 2003; 26:103-106.
22. Vincent M, Ho C, Tomiak A, Winquist E, Whiston F, Stitt L. Toxicity analysis of the 5-day bolus 5-fluorouracil/folinic acid regimen for the treatment of colorectal carcinoma from 2 randomized controlled trials: a concern about dose. Clin Colorectal Cancer 2002; 2:111-118.
23. Rougier P, Lepille D, Bennouna J, et al. Antitumour activity of three second-line treatment combinations in patients with metastatic colorectal cancer after optimal 5-FU regimen failure: a randomised, multicentre phase II study. Ann Oncol 2002; 13:1558-1567.
24. de Gramont A, Vignoud J, Tournigand C, et al. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer 1997; 33:214-219.